Concepedia

Tobias Ginman

TG

Statistics

Publications

7

Citations

253

H-Index

7

Active since

2011

Affiliations

Sprint Bioscience (Sweden)(Current)

AstraZeneca (Sweden)

Bayer (Germany)

Karolinska University Hospital

Karolinska Institutet

Tobias Ginman is an author at Sprint Bioscience (Sweden) specializing in pharmacology, pharmacy, and drug discovery.

Publications per year

2011–2020

7

Publications

7

New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain

Ylva Gravenfors, Jenny Viklund, Jan Blid et al. · Journal of Medicinal Chemistry · 2012 · 65 citations · Full text

, , +11

Novel Class of Potent and Cellularly Active Inhibitors Devalidates MTH1 as Broad-Spectrum Cancer Target

Manuel Ellermann, Ashley Eheim, Fredrik Rahm et al. · ACS Chemical Biology · 2017 · 57 citations · Full text

, , +10

Core Refinement toward Permeable β-Secretase (BACE-1) Inhibitors with Low hERG Activity

Tobias Ginman, Jenny Viklund, Jonas Malmström et al. · Journal of Medicinal Chemistry · 2012 · 40 citations · Full text

, , +16

Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug Design

Fredrik Rahm, Jenny Viklund, L. Tresaugues et al. · Journal of Medicinal Chemistry · 2018 · 33 citations · Full text

, , +16

Pharmacokinetic profile of N-acetylcysteine amide and its main metabolite in mice using new analytical method

Rui He, Wenyi Zheng, Tobias Ginman et al. · European Journal of Pharmaceutical Sciences · 2019 · 33 citations

, , +8

1–5 of 7